文献速递先天性心脏病外科

高危Fontan完成患者围术期风险低且7年后仍获益于腔肺连接

High-risk Fontan completion patients achieve low perioperative risk and benefit from cavopulmonary connection 7 years out†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

结果显示各组术后并发症率无差异,高危组导管再干预率更高,但中期获益仍可取得,提示历史选择标准应重新审视。

要点

  • 超出历史风险因素的高危患儿术后并发症率与低危组无显著差异
  • 高危组远期导管再干预率更高(22%或24% vs 7%,P<0.05)
  • 历史Fontan选择标准可能需要重新评估

核心结论

  • 高危患者同样可获得Fontan完成的中期获益,历史选择标准应重新审视。

研究设计与样本

  • 分三组:超出6项历史风险因素者(n=105)、超出2项风险因素者(n=49)、无禁忌低危组(n=28)。

主要发现

  • 术后心律失常:18%(P=0.3)或18%(P=0.3)vs 25%;感染:22%(P=0.6)或33%(P=0.2)vs 21%。
  • 脑血管意外:6%(P=0.5)或10%(P=0.3)vs 4%;住院天数:20天(P=0.4)或23天(P=0.2)vs 21天;胸引时间P=0.5。
  • 每组各有1例出院前死亡;远期适合关闭开窗者:95%(P=0.7)或95%(P=0.7)vs 92%。
  • 远期心律失常:11%(P=0.5)或12.5%(P=0.3)vs 7%;蛋白丢失性肠病:1%(P=0.1)或2%(P=0.3)vs 7%;中重度以上心室功能不全:2%(P=0.7)或4%(P=0.7)vs 4%。
  • 高危组导管再干预率更高:22%(P<0.05)或24%(P<0.05)vs 7%。

临床怎么用

  • 对传统高危标准下的患儿,Fontan完成仍可考虑,但需关注更高的导管再干预需求。

局限性

  • 回顾性单中心设计,各组样本量不均衡,高危组例数少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Our unit has pursued Fontan completion in all patients except those with immobility or combined poor ventricular function and high pulmonary artery pressures. We assessed retrospectively whether conventional high-risk criteria would predict patients with a poorer outcome. METHODS: One hundred and thirty-three consecutive children who underwent extracardiac Fontan completion (2004-2012) had their outcomes recorded (mean follow-up of 7 years). Three groups were analysed: those with 1 of 6 historical risk factors (outside 6 commandments), those with 1 of reduced systemic ventricular function or pulmonary artery pressure >15 mmHg (outside 2 commandments) versus those with no contraindications. The Fischer's exact test examined frequency differences, with the χ2 test to look for outcome associations. RESULTS: There were no differences in postoperative complication rates between the outside 6 commandments (n = 105) or outside 2 commandments (n = 49) versus the low-risk no-contraindication group (n = 28): arrhythmias [18% (P = 0.3) or 18% (P = 0.3) vs 25%], infection [22% (P = 0.6) or 33% (P = 0.2) vs 21%], cerebrovascular accident [6% (P = 0.5) or 10% (P = 0.3) vs 4%], length of stay [20 days (P = 0.4) or 23 days (P = 0.2) vs 21 days] and duration of chest drainage (P = 0.5). There was 1 predischarge mortality in each group. Long term, the majority of patients in each group had suitable haemodynamics for fenestration closure [95% (P = 0.7) or 95% (P = 0.7) vs 92%]. Long term, there was no difference in the rate of arrhythmias [11% (P = 0.5) or 12.5% (P = 0.3) vs 7%], protein-losing enteropathy [1% (P = 0.1) or 2% (P = 0.3) vs 7%] or moderate or more ventricular dysfunction on echocardiography [2% (P = 0.7) or 4% (P = 0.7) vs 4%]. Notably, there was a higher rate of catheter reinterventions in the high-risk groups [22% (P < 0.05) or 24% (P < 0.05) vs 7%]. CONCLUSIONS: The medium-term benefits of Fontan completion can be achieved for high-risk patients, suggesting that historical selection criteria should be re-examined.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Vigano G, McMahon CJ, Walsh K, et al. High-risk Fontan completion patients achieve low perioperative risk and benefit from cavopulmonary connection 7 years out†. Eur J Cardiothorac Surg. 2019. PMID: 30932144. doi:10.1093/ejcts/ezz069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。